ESTA vs GMED
ESTA: A global medical technology company revolutionizing the breast aesthetics and reconstruction market through its proprietary, safety-focused Motiva Implants and minimally invasive surgical platforms. GMED: Globus Medical is a leading medical technology company specializing in advanced musculoskeletal implants and robotic-assisted surgical platforms for spine procedures.
Side-by-side fundamentals
| Metric | ESTA | GMED | Edge |
|---|---|---|---|
| Price as of 2026-08-07 close | $77.42 | $82.35 | |
| Market cap as of 2026-08-10 | $2.3B | $11.1B | |
| P/E as of 2026-08-10 | n/a | 20.87 | |
| PEG as of 2026-08-10 | n/a | 0.41 | |
| Net margin as of 2026-08-10 | -19.1% | +17.0% | GMED higher |
| Gross margin as of 2026-08-10 | +70.1% | +68.5% | ESTA higher |
| Operating margin as of 2026-08-10 | -12.4% | +20.6% | GMED higher |
| ROE as of 2026-08-10 | -225.9% | +11.6% | GMED higher |
| ROA as of 2026-08-10 | -12.7% | +10.0% | GMED higher |
| Debt / equity as of 2026-08-10 | 17.58 | 0.00 | GMED lower |
| Revenue growth (YoY) as of 2026-08-10 | +34.9% | +19.7% | ESTA higher |
| Revenue CAGR (3y) SEC XBRL | +9.3% | +42.2% | GMED higher |
| Beta as of 2026-08-10 | 1.06 | 0.96 | |
| 1-year return as of 2026-08-07 close | +115.3% | +52.3% | ESTA higher |
Fundamentals: market data, as of 2026-08-10. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-08-07.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.